Sulkowski M - Search Results

1

Ledipasvir and sofosbuvir in patients with genotype 1 hepatitis C virus infection and compensated cirrhosis: An integrated safety and efficacy analysis.

Reddy KR, Bourlière M, Sulkowski M, Omata M, Zeuzem S, Feld JJ, Lawitz E, Marcellin P, Welzel TM, Hyland R, Ding X, Yang J, Knox S, Pang P, Dvory-Sobol H, Subramanian GM, Symonds W, McHutchison JG, Mangia A, Gane E, Mizokami M, Pol S, Afdhal N. Reddy KR, et al. Among authors: sulkowski m. Hepatology. 2015 Jul;62(1):79-86. doi: 10.1002/hep.27826. Epub 2015 May 9. Hepatology. 2015. PMID: 25846144 Clinical Trial.

2

HIV and hepatitis C virus co-infection.

Sulkowski M. Sulkowski M. Hopkins HIV Rep. 1998 Nov;10(6):8, 12. Hopkins HIV Rep. 1998. PMID: 11366132

3

Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: role of hepatitis C and B infections.

Sulkowski MS, Thomas DL, Mehta SH, Chaisson RE, Moore RD. Sulkowski MS, et al. Hepatology. 2002 Jan;35(1):182-9. doi: 10.1053/jhep.2002.30319. Hepatology. 2002. PMID: 11786975

4

Treatment of chronic hepatitis C: a systematic review.

Chander G, Sulkowski MS, Jenckes MW, Torbenson MS, Herlong HF, Bass EB, Gebo KA. Chander G, et al. Hepatology. 2002 Nov;36(5 Suppl 1):S135-44. doi: 10.1053/jhep.2002.37146. Hepatology. 2002. PMID: 12407587 Review.

5

Role of liver biopsy in management of chronic hepatitis C: a systematic review.

Gebo KA, Herlong HF, Torbenson MS, Jenckes MW, Chander G, Ghanem KG, El-Kamary SS, Sulkowski M, Bass EB. Gebo KA, et al. Among authors: sulkowski m. Hepatology. 2002 Nov;36(5 Suppl 1):S161-72. doi: 10.1053/jhep.2002.36989. Hepatology. 2002. PMID: 12407590 Review.

6

Anemia in the treatment of hepatitis C virus infection.

Sulkowski MS. Sulkowski MS. Clin Infect Dis. 2003;37 Suppl 4:S315-22. doi: 10.1086/376911. Clin Infect Dis. 2003. PMID: 14582000

7

The impact of peginterferon alfa-2a plus ribavirin combination therapy on health-related quality of life in chronic hepatitis C.

Hassanein T, Cooksley G, Sulkowski M, Smith C, Marinos G, Lai MY, Pastore G, Trejo-Estrada R, Horta E Vale A, Wintfeld N, Green J. Hassanein T, et al. Among authors: sulkowski m. J Hepatol. 2004 Apr;40(4):675-81. doi: 10.1016/j.jhep.2003.12.014. J Hepatol. 2004. PMID: 15030985 Clinical Trial.

8

Changes in haemoglobin during interferon alpha-2b plus ribavirin combination therapy for chronic hepatitis C virus infection.

Sulkowski MS, Wasserman R, Brooks L, Ball L, Gish R. Sulkowski MS, et al. J Viral Hepat. 2004 May;11(3):243-50. doi: 10.1111/j.1365-2893.2004.00490.x. J Viral Hepat. 2004. PMID: 15117326 Clinical Trial.

9

Epoetin alfa maintains ribavirin dose in HCV-infected patients: a prospective, double-blind, randomized controlled study.

Afdhal NH, Dieterich DT, Pockros PJ, Schiff ER, Shiffman ML, Sulkowski MS, Wright T, Younossi Z, Goon BL, Tang KL, Bowers PJ; Proactive Study Group. Afdhal NH, et al. Gastroenterology. 2004 May;126(5):1302-11. doi: 10.1053/j.gastro.2004.01.027. Gastroenterology. 2004. PMID: 15131791 Clinical Trial.

10

Epoetin alfa improves quality of life in anemic HCV-infected patients receiving combination therapy.

Pockros PJ, Shiffman ML, Schiff ER, Sulkowski MS, Younossi Z, Dieterich DT, Wright TL, Mody SH, Tang KL, Goon BL, Bowers PJ, Leitz G, Afdhal NH; PROACTIVE Study Group. Pockros PJ, et al. Hepatology. 2004 Dec;40(6):1450-8. doi: 10.1002/hep.20482. Hepatology. 2004. PMID: 15565613 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

435 results

Search Page

Filters